BPC-157 has been shown to improve healing in the musculoskeletal system, while TB-500 has been shown to improve healing in a wide range of tissues, including the heart and brain
The buttock: Your upper outer buttocks, or Dorsogluteals, on either side of your body, are common injection sites
Real-world dosing and outcomes 6-month persister loss about 12-13% (Hankosky DOM 2025), broad-cohort about -9.8% (Adamidis Cureus 2026), telehealth completers near -23% (Duncan Obesity Pillars 2026)
If youre worried about pain they use tiny IV needles (22 gauge I think) and you can barely feel it
They help make sure youre getting the right dose, how to get it, and check on how youre doing
Critical safety considerations for laboratory use include potential immunogenicity concernswith peptide therapeutics commonly showing injection site reactions (20-40% with subcutaneous administration) and possible antidrug antibody formationalong with theoretical concerns that pro-angiogenic properties could potentially influence experimental tumor models, requiring appropriate controls in oncology-related research